By Topic

Constrained intervention in a cancerous mammalian cell cycle network

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

5 Author(s)
Faryabi, B. ; Dept. of Electr. & Comput. Eng., Texas A&M Univ., College Station, TX ; Vahedi, G. ; Chamberland, J.-F. ; Datta, A.
more authors

Cancer therapy options are directed at eradicating cancerous cells. Unfortunately, cancer treatments may also damage healthy cells. The result of this damage is side effects of the treatment. It is desirable to maintain the side effects below an acceptable threshold. This goal can be facilitated by enforcing an upper bound on the expected number of treatments a patient may receive during her/his therapy. In this paper, an appropriate therapeutic policy for a mutated mammalian cell cycle is devised. This policy mitigates the side effects of the therapy by bounding the expected number of treatments received by a patient.

Published in:

Genomic Signal Processing and Statistics, 2008. GENSiPS 2008. IEEE International Workshop on

Date of Conference:

8-10 June 2008